This paper didn't get as much attention as it deserved back in 2015 and advances have been made in the delivery of light from outside the body to effectively treat different types of cancer. The use of photobiomodulation as a direct form of stimulation to improve immune functions has been attracting considerable attention over the past 7 years for a wide range of neurodegenerative and neuropsychiatric disorders as well in photodynamic therapy in oncology.
Optogenetics has created a vehicle for infrared light to trigger the release of chemotherapy drugs at the tumor site and thereby reducing medication side effects and improving treatment outcomes. Photobiomodulation will improve circulation and ATP production which can be very helpful in specific treatment protocols. Quietmind's focus has been on neurodegenerative disorders but will soon be considering a study to examine how infrared light therapy can be helpful for certain types of skin cancer.
Read here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782038/
Prinsloo,S.,et al., Functional brain training alleviates chemotherapy-induced peripheral nerve damage in cancer survivors. Journal of Clinical Pathways. 2017;3(3):10-14.
Alvarez,J., Neurofeedback for treatment of 'brain fog' from chemotherapy. 8th International Conference of the Society for Integrative Oncology. Presented November 12, 2011
Those clinicians working with psychiatrically disabled people have known about the negative effects of antipsychotic medications used to control more serious negative symptoms. This controlled clinical trial report shows how some antipsychotic medications cause a 10% shrinkage of total brain volume and increased risk of death in children.
These findings have consequences across all aspects of our cognitive, motor and emotional functioning and therefore reinforces the value of trying less invasive methods of treatment before resorting to antipsychotic medication. Neurofeedback, neurotherapies (TDCS, TACS, rTMS) and photobiomodulation are some of the options that should be considered ahead of or in combination with medication to augment medication effects while decreasing severity of side effects. This was shown to work with chemotherapy-induced peripheral neuropathy brain fog in woman undergoing treatment for breast cancer. (Alvarez,2017)
I don't really see how much I need to add to a report about the need to know how to breathe properly. I can only suggest that it is critically important and serves as a central feature of the work I do with the folks I consult with on improving their physical, mental and emotional health. The other point I can make is that knowing how to breathe and using that knowledge last month likely saved my life as I dealt with being infected with the COVID-19 virus. I also credit 5 days of clarithromycin and megadoses of Vitamin C and D and lots of morning sunshine and the love and care of my wife Nancy. When it came to the contractions and constant pressure in my lungs and chest, I needed to work on deepening (diaphragmatic) and slowing my respiration to 6/minute, I was glad to know what had to be done.
I regret this is behind the WSJ paywall so maybe someone with a subscription can share the full text. https://www.wsj.com/articles/the-healing-power-of-proper-breathing-11590098696?mod=e2fb
I've commented before about the use of ultraviolet light wavelengths as a way to kill viruses and bacteria on surfaces. I'm happy now that we can add skin surfaces to this list with the use of a smaller band of UVC frequencies that won't harm human tissue. This represents a major advanc in our ability to prevent spread of the COVID 19 and other viruses by exposing them to these light frequencies. Products that can clean air ducts and hospital rooms will soon be helping stop the spread of the pandemic virus without harming people, animals or the environment.
Quietmind Foundation's clinical facility in Elkins Park uses UVC to clean all the electronic equipment and surfaces in our treatment space and waiting area overnight. We continue to use the standard methods of masks, hand washing and Clorox wipes for some surfaces including everyone's shoes before they enter. This is a really great advance using noninvasive and environmentally friendly technology to serve a very serious heath and safety need.
I located this bulb on Amazon and it delivers the far-UVC range of frequencies and covers a 30x20' space which is perfect for my consulting area at work. I can run the unit between sessions and have a virus free environment that won't cause skin damage or harm electronics.
Welch, D., Buonanno, M., Grilj, V. et al. Far-UVC light: A new tool to control the spread of airborne-mediated microbial diseases. Sci Rep 8, 2752 (2018). https://doi.org/10.1038/s41598-018-21058-w
This article brings a greater level of clarity to the argument for APA and DSMV to validate and integrate neuroimaging data into psychiatric diagnosis and treatment. Further, we advocate the use of Quantitative EEG (QEEG) assessment technology because it offers the best temporal and spatial resolution of current imaging techniques. Quietmind Fdn. has used QEEG in its clinical research and treatment programs for 10+ years to determine the training protocols needed for people to improve their cognitive and behavioral functioning.
Download the article here:
We are now working with the development team at Independence Lighting (ILED) in Berwyn, PA to promote the development of innovative noninvasive non-drug treatment options for physical and behavioral symptoms of COVID-19 pandemic Our prior focus has been on studying treatments that employ infrared light and brainwave biofeedback for neuropsychiatric, neurodegenerative and neurodevelopmental disorders. Our goal is to help Independence LED create a save, low-cost, reliable and easily deployed device that can help reduce the chances of developing symptoms and reducing severity in those already infected.
We are seeking support for the initial basic science research we have proposed that will clarify the mechanisms that underlie treatment effectiveness. With the evidence from these studies ILED will then produce a device that can be scaled and distributed worldwide. You can review the basic science proposal here.
PBM Treatment Potential for COVID-19
There is a growing body of evidence showing that pulsed 1068nm infrared stimulation could serve as the basis for a safe, low-cost, non-drug, easily-deployed, noninvasive and home-based treatment for COVID-19. Current research evidence includes photobiomodulation as:
Please contact Dr. Marvin Berman 610-940-0488 for details.
I learned about neurofeedback in 1996 through the original Low Energy Neurotherapy System (LENS) developed by Len Ochs, PhD that delivered miniscule amounts of electromagnetic stimulation that was tied to the EEG's dominant frequency (DF). The DF was determined by sampling the EEG at 256 samples/sec and taking a running average of the measured frequencies between 1-30hz. The 'stimulation' that was delivered was offset above or below the DF.
I observed the DF behavior and noticed that there were consistent patterns in both its range and variability. I suggested using the DF with no offset so as to provide the patient with a mirror experience to evoke what is described as a mirroring transference in object relations theory. This experience of what is coming in from outside is the same as what is experienced inside would then offer the closest resonance to the intrauterine state. From there we can reconstruct a healthier pattern of relatedness that’s functionally grounded in optimizing neuro adaptiveness that can be operationally defined as the absolute DF range and variability with the range.
The recent white paper by Michael Hamblin, PhD and Lew Lim, Vielight Inc. CEO, discusses the potential value of near infrared light stimulation using continuous 810nm photobiomodulation (PBM) along with 633nm intranasal stimulation. There is compelling evidence in the scientific literature supporting the therapeutic value of light stimulation to promote tissue level healing and ongoing neuroprotection. Quietmind Foundation has been studying the clinical value of photobiomodulation using Vielight and other PBM devices over the past 15 years and we now strongly advocate its inclusion along with central and peripheral biofeedback training in the treatment of neurodegenerative, neuropsychiatric and neurodevelopmental disorders. The evidence presented in this paper lends support for using PBM as a treatment for COVID-19 and other localized and systemic infections.
QMF has already developed a research protocol and is seeking support to conduct studies that will provide evidence for the efficacy of PBM as a noninvasive treatment to boost immune response to COVID-19. We have been given a challenge grant that will match tax deductible donations up to $12,000 toward our goal of $45,000.
We are providing the X-plus, when they become available, with a 10% discount and no cost technical and clinical support. Please contact Dr. Marvin Berman for details at 610-940-0488.
Continuing the theme of what can we do right now to prevent infection with CV19, I want to stress the importance of aerobic exercise which stimulates the production of a powerful antioxidant "extracellular superoxide dismutase" (EcSOD). Exercise that increases breathing rate, depth and elevates heart rate will produce EcSOD. This is a very direct way we all can act to prevent infection and to improve our rate of recovery. I can attest to this from my own personal experience with recovering from CV19 infection last month. I practiced breathing techniques to deepen my intake to lower lobes, slowed my rate to 6 breaths a minute and climbed stairs in my South Philly row home (of which there are many) to get my heart rate up during my quarantine period. I think this routine along with infrared light stimulation and megadosing VitC and D helped me recover without heart, lung or kidney damage.
This review paper by Zhen Yan, PhD, of the University of Virginia School of Medicine underscores the potential value of exercise as a way to prevent and/or minimize the severity of COVID-19 infection. Quietmind Fdn. is offering consultation and support for people seeking to noninvasively promote their resistance to COVID-19 infection. Call Dr. Berman at 610-940-0488 for further information.
Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general.